Free Trial

Methanex (NASDAQ:MEOH) Given a $45.00 Price Target at Raymond James Financial

Methanex logo with Basic Materials background

Methanex (NASDAQ:MEOH - Get Free Report) TSE: MX has been assigned a $45.00 price target by Raymond James Financial in a research report issued to clients and investors on Tuesday, July 15th, Marketbeat Ratings reports. The firm presently has an "outperform" rating on the specialty chemicals company's stock. Raymond James Financial's target price indicates a potential upside of 31.31% from the stock's current price. Raymond James Financial also issued estimates for Methanex's Q2 2025 earnings at $0.40 EPS, Q3 2025 earnings at $0.72 EPS, Q4 2025 earnings at $1.27 EPS, FY2025 earnings at $3.69 EPS and FY2026 earnings at $4.20 EPS.

Other analysts have also issued research reports about the stock. Piper Sandler set a $48.00 price target on shares of Methanex and gave the stock an "overweight" rating in a research report on Sunday, May 18th. Wall Street Zen lowered shares of Methanex from a "buy" rating to a "hold" rating in a research report on Thursday, May 1st. JPMorgan Chase & Co. assumed coverage on shares of Methanex in a research report on Tuesday, June 10th. They set a "neutral" rating and a $33.00 price target on the stock. Barclays reduced their price target on shares of Methanex from $57.00 to $41.00 and set an "equal weight" rating on the stock in a research report on Tuesday, April 1st. Finally, CIBC dropped their price objective on shares of Methanex from $47.00 to $44.00 and set an "outperformer" rating for the company in a research note on Monday, May 5th. Four equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Methanex presently has an average rating of "Moderate Buy" and an average price target of $45.63.

Check Out Our Latest Analysis on MEOH

Methanex Stock Performance

Shares of NASDAQ:MEOH traded up $0.76 on Tuesday, reaching $34.27. 704,120 shares of the company's stock were exchanged, compared to its average volume of 555,275. The company has a fifty day moving average of $34.02 and a 200-day moving average of $37.41. Methanex has a twelve month low of $25.46 and a twelve month high of $54.49. The company has a market capitalization of $2.65 billion, a price-to-earnings ratio of 11.50 and a beta of 0.92. The company has a current ratio of 3.17, a quick ratio of 2.52 and a debt-to-equity ratio of 0.94.

Methanex (NASDAQ:MEOH - Get Free Report) TSE: MX last posted its quarterly earnings results on Wednesday, April 30th. The specialty chemicals company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.25 by $0.05. The business had revenue of $857.90 million for the quarter, compared to analyst estimates of $1.06 billion. Methanex had a net margin of 6.00% and a return on equity of 12.45%. The firm's revenue for the quarter was down 2.2% on a year-over-year basis. During the same quarter last year, the business posted $0.65 EPS. On average, research analysts predict that Methanex will post 4.32 EPS for the current fiscal year.

Hedge Funds Weigh In On Methanex

Hedge funds have recently bought and sold shares of the company. Pictet Asset Management Holding SA grew its holdings in shares of Methanex by 2.6% during the fourth quarter. Pictet Asset Management Holding SA now owns 11,463 shares of the specialty chemicals company's stock valued at $573,000 after buying an additional 293 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in Methanex by 3.4% during the 4th quarter. Ameriprise Financial Inc. now owns 11,778 shares of the specialty chemicals company's stock worth $588,000 after acquiring an additional 383 shares during the period. Value Partners Investments Inc. grew its stake in Methanex by 7.3% in the 4th quarter. Value Partners Investments Inc. now owns 6,053 shares of the specialty chemicals company's stock worth $302,000 after buying an additional 411 shares in the last quarter. Signaturefd LLC boosted its stake in shares of Methanex by 15.0% in the 4th quarter. Signaturefd LLC now owns 3,452 shares of the specialty chemicals company's stock valued at $172,000 after purchasing an additional 450 shares in the last quarter. Finally, Nebula Research & Development LLC boosted its position in Methanex by 4.7% during the 4th quarter. Nebula Research & Development LLC now owns 10,180 shares of the specialty chemicals company's stock valued at $508,000 after buying an additional 454 shares during the period. Institutional investors own 73.49% of the company's stock.

About Methanex

(Get Free Report)

Methanex Corporation produces and supplies methanol in China, Europe, the United States, South America, South Korea, Canada, and Asia. The company also purchases methanol produced by others under methanol offtake contracts and on the spot market. In addition, it owns and leases storage and terminal facilities.

Further Reading

Analyst Recommendations for Methanex (NASDAQ:MEOH)

Should You Invest $1,000 in Methanex Right Now?

Before you consider Methanex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Methanex wasn't on the list.

While Methanex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines